Plasma proteomic analysis of patients infected with H1N1 influenza virus

Proteomics

Volumn 14, Issue 16, 2014, Pages 1933-1942

  Choi, Seonyoung ^a   Lim, Ji youn ^a   Kim, Yoonjin ^a   Song, Moon Jung ^b   Jung, Woon Won ^c   Seo, Jung Bok ^d   Lee, Jacob ^e   Sul, Donggeun ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Chongju University   (South Korea)

^d Korea Basic Science Institute (KBSI)   (South Korea)

^e Hallym University   (South Korea)

Author keywords

Biomarkers; Biomedicine; H1N1; Influenza virus; Plasma proteins

Indexed keywords

ALPHA2 GLYCOPROTEIN; AXIN INTERACTOR DORSALIZATION ASSOCIATED PROTEIN; BIOLOGICAL MARKER; CALGRANULIN A; CLUSTERIN; DUAL OXIDASE 1; FLOTILLIN 1; OXIDOREDUCTASE; PLASMA PROTEIN; PROTEIN CCDC30; PROTEIN DUOX1; PROTEIN FAM157A; PROTEIN KINASE C DELTA BINDING PROTEIN; PROTEIN SMARCD3; SERUM AMYLOID A; T CELL RECEPTOR GAMMA CHAIN V REGION PT GAMMA 1 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEOMICS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; BLOOD; HOST PATHOGEN INTERACTION; INFLUENZA; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; BLOOD PROTEINS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS;

EID: 84905691997     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400030     Document Type: Article

References (34)

1. Choi, K., Cho, S. I., Hashizume, M., Kim, H., Epidemiological characteristics of novel influenza A (H1N1) in antiviral drug users in Korea. PLoS One 2012, 7, e47634.
2. Kohen, R., Nyska, A., Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002, 30, 620-650.
3. Nikam, S. V., Nikam, P. S., Chandrashekar, M. R., Kalsad, S. T. et al., Role of lipid peroxidation, glutathione and antioxidant enzymes in H1N1 Influenza. Biomed. Res. 2010, 21, 457-560.
4. Vijaya Lakshmi, A. N., Ramana, M. V., Vijayashree, B., Ahuja, Y. R. et al., Detection of influenza virus induced DNA damage by comet assay. Mutat. Res. 1999, 442, 53-58.
5. Kumar, P., Sharma, S., Khanna, M., Raj, H. G., Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int. J. Exp. Pathol. 2003, 84, 127-133.
6. Vester, D., Rapp, E., Gade, D., Genzel, Y. et al., Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics 2009, 9, 3316-3327.
7. Coombs, K. M., Berard, A., Xu, W., Krokhin, O. et al., Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J. Virol. 2010, 84, 10888-10906.
8. Emmott, E., Wise, H., Loucaides, E. M., Matthews, D. A. et al., Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells. J. Proteome Res. 2010, 9, 5335-5345.
9. Lietzén, N., Ohman, T., Rintahaka, J., Julkunen, I. et al., Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog. 2011, 7, e1001340.
10. Zhu, J., Zou, W., Jia, G., Zhou, H. et al., Analysis of cellular proteome alterations in porcine alveolar macrophage cells infected with 2009 (H1N1) and classical swine H1N1 influenza viruses. J. Proteomics 2012, 75, 1732-1741.
11. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
12. Guipaud, O., Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases. Adv. Exp. Med. Biol. 2013, 990, 61-86.
13. Stockley, R. A., Measurement of soluble proteins in lung secretions. Thorax 1984, 39, 241-247.
14. van Diepen, A., Brand, H. K., Sama, I., Lambooy, L. H. et al., Quantitative proteome profiling of respiratory virus-infected lung epithelial cells. J. Proteomics 2010, 73, 1680-1693.
15. Andersen, J. D., Boylan, K. L., Jemmerson, R., Geller, M. A. et al., Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J. Ovarian Res. 2010, 3, 21.
16. Li, Y., Zhang, Y., Qiu, F., Qiu, Z., Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis 2011, 32, 1976-1983.
17. Cummings, C., Walder, J., Treeful, A., Jemmerson, R., Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay. Apoptosis 2006, 11, 1121-1129.
18. Kawakami, T., Hoshida, Y., Kanai, F., Tanaka, Y. et al., Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. Proteomics 2005, 5, 4287-4295.
19. Okano, T., Kondo, T., Kakisaka, T., Fujii, K. et al., Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 2006, 6, 3938-3948.
20. Lin, C. P., Chen, Y. W., Liu, W. H., Chou, H. C. et al., Proteomic identification of plasma biomarkers in uterine leiomyoma. Mol. Biosyst. 2012, 8, 1136-1145.
21. Kakisaka, T., Kondo, T., Okano, T., Fujii, K. et al., Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 852, 257-267.
22. Ladd, J. J., Busald, T., Johnson, M. M., Zhang, Q. et al., Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev. Res. 2012, 5, 655-664.
23. Watson, C. J., Ledwidge, M. T., Phelan, D., Collier, P. et al., Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure. Circ. Heart Fail. 2011, 4, 188-197.
24. Rigutto, S., Hoste, C., Grasberger, H., Milenkovic, M. et al., Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. Biol. Chem. 2009, 284, 6725-6734.
25. Geiszt, M., Witta, J., Baffi, J., Lekstrom, K. et al., Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 2003, 17, 1502-1504.
26. Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H. C. et al., Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 1986, 261, 9644-9651.
27. Uhlar, C. M., Whitehead, A. S., Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999, 265, 501-523.
28. Miwata, H., Yamada, T., Okada, M., Kudo, T. et al., Serum amyloid A protein in acute viral infections. Arch. Dis. Child 1993, 68, 210-214.
29. Hultén, C., Sandgren, B., Skiöldebrand, E., Klingeborn, B. et al., The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine influenza virus infection. Acta Vet. Scand. 1999, 40, 323-333.
30. Falsey, A. R., Walsh, E. E., Francis, C. W., Looney, R. J. et al., Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J. Infect. Dis. 2001, 183, 995-999.
31. Zhang, N., Ahsan, M. H., Purchio, A. F., West, D. B., Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J. Immunol. 2005, 174, 8125-8134.
32. Ren, Y., Wang, H., Lu, D., Xie, X. et al., Expression of serum amyloid A in uterine cervical cancer. Diagn. Pathol. 2014, 21, 9-16.
33. Braga, E. A., Kashuba, V. I., Maliukova, A. V., Loginov, V. I. et al., New tumor suppressor genes in hot spots of human chromosome 3: new methods of identification. Mol. Biol. (Mosk) 2003, 37, 194-211.
34. Monto, A. S., Epidemiology of viral respiratory infections. Am. J. Med. 2002, 22 (112 Suppl 6A), 4S-12S.